Epitope mapping of prostate-specific antigen with monoclonal antibodies.

Prostate-specific antigen (PSA) is a widely used marker for screening and monitoring prostate cancer. We identified and characterized the epitopes of two anti-PSA monoclonal antibodies (mAbs) designated B80 and B87. The epitopes were initially mapped as nonoverlapping by developing a sandwich immunoassay to measure PSA with the two anti-PSA mAbs. The two antibodies do not cross-react with homologous pancreatic kallikrein, but recognize epitopes unique to PSA. B80 and B87 can recognize both free and complexed PSA and hence measure total PSA. Epitope scanning and bacteriophage peptide library affinity selection procedures were used to identify and locate an epitope on PSA. A possible epitope for B80 was identified as being located on or near PSA amino acid residues 50-58 (-GRH-SLFHP-). The epitope for B87 was likely on an exposed nonlinear conformational determinant, unique to PSA, and not masked by the binding of B80 or alpha 1-antichymotrypsin.

[1]  J. Oesterling,et al.  Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. , 1995, Urology.

[2]  D. Bridon,et al.  Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. , 1995, Urology.

[3]  M. Vihinen.  Modeling of prostate specific antigen and human glandular kallikrein structures. , 1994, Biochemical and biophysical research communications.

[4]  T. Bacarese-Hamilton,et al.  SR1 assays of alpha-fetoprotein, carcinoembryonic antigen, and prostate-specific antigen compared with corresponding established commercial assays. , 1994, Clinical chemistry.

[5]  David S. Wishart,et al.  SEQSEE: a comprehensive program suite for protein sequence analysis , 1994, Comput. Appl. Biosci..

[6]  R. Cattini,et al.  Measurement of prostate-specific antigen in serum using four different immunoassays. , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[7]  W. Catalona,et al.  Using PSA to screen for prostate cancer. The Washington University experience. , 1993, The Urologic clinics of North America.

[8]  B. Bluestein,et al.  Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. , 1993, Clinical chemistry.

[9]  H. C. Graves,et al.  Standardization of immunoassays for prostate‐specific antigen. A problem of prostate‐specific antigen complexation or a problem of assay design? , 1993, Cancer.

[10]  C. Ed,et al.  PSA as a screening test for prostate cancer. , 1993 .

[11]  P. Schellhammer,et al.  Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers. , 1993, The Urologic clinics of North America.

[12]  R. Vessella,et al.  Issues in the assessment of PSA immunoassays. , 1993, The Urologic clinics of North America.

[13]  R. Vessella.  Trends in immunoassays of prostate-specific antigen: serum complexes and ultrasensitivity. , 1993, Clinical chemistry.

[14]  O. Carretero,et al.  The molecular biology of the kallikrein-kinin system: III. The human kallikrein gene family and kallikrein substrate. , 1993, Journal of hypertension.

[15]  O. Nilsson,et al.  Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.

[16]  R. Zuckermann,et al.  Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage. , 1992, Journal of molecular biology.

[17]  P. Riegman,et al.  Characterization of the human kallikrein locus. , 1992, Genomics.

[18]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[19]  H. Lilja,et al.  Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. , 1990, European journal of biochemistry.

[20]  R. Barrett,et al.  Peptides on phage: a vast library of peptides for identifying ligands. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[22]  J. Devlin,et al.  Random peptide libraries: a source of specific protein binding molecules. , 1990, Science.

[23]  J. Drago,et al.  Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience. , 1989, Urology.

[24]  L. Sottrup-jensen.  Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. , 1989, The Journal of biological chemistry.

[25]  H. Lilja,et al.  Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. , 1989, The Journal of biological chemistry.

[26]  Takanori Nakamura,et al.  The chymotrypsin‐like activity of human prostate‐specific antigen, γ‐seminoprotein , 1987 .

[27]  H. Lilja,et al.  Molecular cloning of human prostate specific antigen cDNA , 1987, FEBS letters.

[28]  K. Fujikawa,et al.  Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. , 1986, Biochemistry.

[29]  K. Watt,et al.  Human prostate-specific antigen: structural and functional similarity with serine proteases. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Lilja.  A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. , 1985, The Journal of clinical investigation.

[31]  H. M. Geysen,et al.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Astill,et al.  Evaluation of free psa isoforms, psa complex formation, and specificity of anti‐psa antibodies by hplc and page‐immunoblotting techniques , 1995, Journal of clinical laboratory analysis.

[33]  J. Clements,et al.  A common nomenclature for members of the tissue (glandular) kallikrein gene families. , 1992, Agents and actions. Supplements.

[34]  U. Stenman,et al.  A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. , 1991, Cancer research.

[35]  T. Marti,et al.  Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma. , 1987, European journal of biochemistry.